This study investigates stereotactic magnetic resonance (MR) guided adaptive radiation therapy in patients with cancer. It explores how this treatment can be adapted for different types of cancer, including pancreatic, lung, and renal cancer.
The study evaluates the safety and effectiveness of using MR-guided radiation therapy. It examines how adjusting radiation treatments based on daily MRI scans may impact tumor control and patient outcomes.
- Who can participate: Adults aged 18 and over with a confirmed malignancy requiring stereotactic body radiation therapy can participate. Tumor size must be 7cm or less, and participants should have an ECOG performance status of 2 or lower.
- Study details: Participants will receive radiation therapy guided by MRI scans. This involves adjusting treatments based on daily imaging to potentially improve outcomes.
How understandable was the trial content above?
Hard to understand
Easy to understand